US 10064901
Compositions and methods
granted A61KA61K35/37A61K35/74
Quick answer
US patent 10064901 (Compositions and methods) held by Seres Therapeutics, Inc. expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Seres Therapeutics, Inc.
- Grant date
- Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K35/37, A61K35/74, A61K35/741, A61K35/742